A novel PET radiotracer that binds to myelin with high affinity is expected to overcome limitations of MRI in diagnosing and monitoring multiple sclerosis — and potentially other diseases of the CNS.
A novel PET radiotracer binds preferentially to myelin to provide unique brain imaging advantages over existing MRI methods. Here’s an overview of its backstory and clinical potential.
Myelin PET offers quantitative imaging of brain microstructure that goes beyond what’s seen with current MRI methods. Here’s how we’re using it in epilepsy — and how we’ll soon be using it in other CNS diseases.